Humanized and chimeric anti-CD59 antibodies that mediate cancer cell cytotoxicity

Details for Australian Patent Application No. 2008255526 (hide)

Owner F.Hoffmann-La Roche AG

Inventors Findlay, Helen P.; Cechetto, Lisa M.; Hahn, Susan E.; Young, David S.F.; Da Cruz, Luis A.G.

Agent Davies Collison Cave

Pub. Number AU-A-2008255526

PCT Pub. Number WO2008/144889

Priority 11/807,681 30.05.07 US

Filing date 23 May 2008

Wipo publication date 4 December 2008

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/144889 Priority application(s): WO2008/144889

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008255527-Chimeric and humanized anti-CD44 antibodies that mediate cancer cell cytotoxicity

2008255525-Formulations for the oral administration of therapeutic agents and related methods